Le Y. Yu
NMPA Key Laboratory For Research And Evaluation Of Drug Metabolism & Guangdong Provincial Key Laboratory Of New Drug Screening & Guangdong Hongkong Macao Joint Laboratory For New Drug Screening
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Preoperative three-dimensional reconstruction facilitates robot-assisted radical nephrectomy and inferior vena cava thrombectomy for renal cell carcinoma: Insights from a Chinese high-volume center.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: April 28, 2026
YAP Upregulation Contributes to Acquired Resistance to BET Inhibitors in Uveal Melanoma.
Journal: Pigment cell & melanoma research
Published: February 20, 2025
BAP1 loss confers sensitivity to bromodomain and extra-terminal inhibitors in renal cell carcinoma.
Journal: Anti-cancer drugs
Published: July 30, 2024
GRP78 Nanobody-Directed Immunotoxin Activates Innate Immunity Through STING Pathway to Synergize Tumor Immunotherapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 15, 2024
Targeted degradation of endogenous YAP by nanobody bioPROTAC inhibits tumor progression.
Journal: Nature communications
Published: March 28, 2024
Polyphyllin VII as a potential medication for targeting epithelial mesenchymal transitionin in thyroid cancer.
Journal: Journal of pharmacological sciences
Published: March 04, 2024
Discontinuation and nonpublication of nasopharyngeal carcinoma clinical trials.
Journal: Oral oncology
Published: September 14, 2023
Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations.
Journal: Pigment cell & melanoma research
Published: August 29, 2023
Beyond canonical PROTAC: biological targeted protein degradation (bioTPD).
Journal: Biomaterials research
Published: January 01, 2023
Glutamine metabolic microenvironment drives M2 macrophage polarization to mediate trastuzumab resistance in HER2-positive gastric cancer.
Journal: Cancer communications (London, England)
Published: October 01, 2022
Last Updated: 09/26/2026